Cadila Pharma launches Posaconazole for treatment of fungal diseases

Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal disease. The drug has also been recommended as a second line treatment for Mucormycosis or black fungus as it is commonly known.